Cargando…

Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism

Doxorubicin is one of the most widely used antitumor drugs and is currently produced via the chemical conversion method, which suffers from high production costs, complex product separation processes, and serious environmental pollution. Biocatalysis is considered a more efficient and environment-fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Gao, Ling-Xiao, Chen, Wei, Zhong, Jian-Jiang, Qian, Chao, Zhou, Wen-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179135/ https://www.ncbi.nlm.nih.gov/pubmed/37176043 http://dx.doi.org/10.3390/ijms24098337

Ejemplares similares

Rational design of cholesterol oxidase for efficient bioresolution of cholestane skeleton substrates
por: Qin, Hui-Min, et al.
Publicado: (2017)

Engineering substrate promiscuity in 2,4-dichlorophenol hydroxylase by in silico design
por: Wang, Ye, et al.
Publicado: (2018)

One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases
por: Mammoli, Andrea, et al.
Publicado: (2021)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

2D Material Nanofiltration Membranes: From Fundamental Understandings to Rational Design
por: Liu, Xiaopeng, et al.
Publicado: (2021)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Synthesis and Cytotoxic Evaluation of Arimetamycin A and Its Daunorubicin and Doxorubicin Hybrids
por: Huseman, Eric D., et al.
Publicado: (2021)

Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
por: Smith, B. J., et al.
Publicado: (1976)

Rational protein design of Bacillus sp. MN chitosanase for altered substrate binding and production of specific chitosan oligomers
por: Gercke, David, et al.
Publicado: (2019)

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells
por: Gao, Chao, et al.
Publicado: (2020)

Structural insights into targeting of the colchicine binding site by ELR510444 and parbendazole to achieve rational drug design
por: Lei, Jia-Hong, et al.
Publicado: (2021)

The Influence of pH and Temperature on the Stability of N-[(Piperidine)methylene]daunorubicin Hydrochloride and a Comparison of the Stability of Daunorubicin and Its Four New Amidine Derivatives in Aqueous Solutions
por: Piekarski, Mikołaj, et al.
Publicado: (2014)

Rational Design of the Soluble Variant of l-Pipecolic Acid Hydroxylase using the α-Helix Rule and the Hydropathy Contradiction Rule
por: Shinoda, Suguru, et al.
Publicado: (2022)

Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core
por: Khoo, Kian Hoe, et al.
Publicado: (2009)

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021)

Biophysically Inspired Rational Design of Structured Chimeric Substrates for DNAzyme Cascade Engineering
por: Lakin, Matthew R., et al.
Publicado: (2014)

Substrate Channeling by a Rationally Designed Fusion Protein in a Biocatalytic Cascade
por: Kummer, Matthew J., et al.
Publicado: (2021)

Dead or alive? The manipulation of neuronal ensembles and pathways by daunorubicin
por: Bashir, Zafar Iqbal, et al.
Publicado: (2017)

Author Correction: Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

The rational dimension of understanding
por: Belkoniene, Miloud
Publicado: (2022)

Exploiting Substrate Promiscuity of Ectoine Hydroxylase for Regio- and Stereoselective Modification of Homoectoine
por: Czech, Laura, et al.
Publicado: (2019)

Studies on the selectivity of proline hydroxylases reveal new substrates including bicycles
por: Smart, Tristan J., et al.
Publicado: (2020)

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
por: Lancet, Jeffrey E., et al.
Publicado: (2018)

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
por: Tefferi, Ayalew, et al.
Publicado: (2022)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells
por: Chen, Bao-an, et al.
Publicado: (2010)

The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
por: Joshi, Shilvi, et al.
Publicado: (2017)

Rational Design and Experimental Analysis of Short-Oligonucleotide Substrate Specificity for Targeting Bacterial Nucleases
por: Jiménez, Tania, et al.
Publicado: (2021)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
por: Bao, Wen, et al.
Publicado: (2019)

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
por: McGown, A., et al.
Publicado: (1987)

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.
por: Slater, L. M., et al.
Publicado: (1986)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
por: Sari, Flori R., et al.
Publicado: (2011)

The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts
por: Dragojew, Sylwia, et al.
Publicado: (2008)

Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells
por: Codini, Michela, et al.
Publicado: (2018)

Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
por: Blair, Hannah A.
Publicado: (2018)

Enhancing the Therapeutic Efficacy of Daunorubicin and Mitoxantrone with Bavachinin, Candidone, and Tephrosin
por: Darzi, Sina, et al.
Publicado: (2019)

Cytarabine/daunorubicin: Coronavirus disease-2019 pneumonia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31f0mnv9bg9k5197l6ho0gmgq4